Why did CTQ.AX stock drop intraday today?

CTQ.AX stock fell due to heavy selling and low liquidity; volume hit **4,306,902** versus average **289,823**. No specific company release drove the move; market reaction to microcap healthcare names and thin order books likely amplified the decline.

What is Meyka AI’s view on CTQ.AX stock?

Meyka AI rates CTQ.AX with a score of **67.29** (Grade B, HOLD). The grade balances sector comparison, growth, metrics and forecasts, but notes limited liquidity and negative EPS as key risks.

What is the price forecast for CTQ.AX stock?

Meyka AI's forecast model projects a near-term level of **A$0.010** and a 12‑month median around **A$0.010**, implying roughly **24.0%** upside from **A$0.008**. Forecasts are model-based projections and not guarantees.

How should traders manage risk in CTQ.AX stock?

Treat CTQ.AX stock as speculative: limit position size, use strict stop-losses, and avoid margin. Monitor liquidity, the earnings date **02 Mar 2026**, and sector headlines that can trigger outsized moves.

AU Stocks

CTQ.AX down 27% intraday on ASX 10 Feb 2026: top loser and outlook

ByHuzaifa Zahoor February 10, 2026

Careteq Limited (CTQ.AX stock) plunged 27.27% intraday to A$0.008 on the ASX on 10 Feb 2026, making it one of the session’s top losers. Trade volume surged to 4,306,902 shares versus an average of 289,823, indicating heavy selling against thin liquidity. Intraday range was A$0.008–0.011, and the sell-off follows limited company news but elevated market sensitivity in small-cap health-tech names. This intraday move is a reminder of volatility in low-price ASX microcaps and why position sizing matters.